Search - tctmd.com

Displaying 81 - 100 of 164

Sort: Relevancy | Date

News Conference News LINC 2020

Lutonix BTK Studies: Below-the-Knee Challenges Linger

L.A. McKeown

January 29, 2020

News Daily News

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

L.A. McKeown

January 15, 2020

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

Presentation TCT 2019

The BTK Interventional Toolbox: Wires and Crossing Devices

Presenter: Ehrin Armstrong

September 28, 2019

Presentation TCT 2019

Understanding BTK Disease: Impact of Lesion Type, Severity, and Location on Technique and Device Selection

Presenter: Sahil Parikh

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

My Toughest BTK Case of the Year

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

Optimal BTK POBA: Is There Science to the Art?

Presenter: Khusrow Niazi

September 25, 2019

Presentation TCT 2019

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

Presenter: Ehrin Armstrong

September 25, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

News Industry News

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

May 07, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

Presentation VIVA 2018

LUTONIX BTK Trial

Presenter: Jihad Mustapha

November 09, 2018

News Conference News VIVA 2018

LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation

L.A. McKeown

November 07, 2018

Presentation TCT 2018

DCB for BTK: Clinical Challenges and Lessons Learned

Presenter: Juan F. Granada, Bruno Scheller, Sahil A. Parikh

September 23, 2018

Presentation TCT 2017

A Novel Micro-stent Technology Platform for BTK Interventions (Micromedical)

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Jihad A. Mustapha

November 01, 2017

Presentation TCT 2017

Trial Strategies to Prove the Value of New BTK Devices

Presenter: Mahmood K. Razavi, Peter A. Schneider

October 31, 2017

Presentation TCT 2017

Maximizing Long-term Outcome: DES, DCB, and Combination Therapies

Presenter: Mahmood K. Razavi, Peter A. Schneider, George L Adams

October 31, 2017

Advertisement

Lutonix BTK Studies: Below-the-Knee Challenges Linger

Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

The BTK Interventional Toolbox: Wires and Crossing Devices

Understanding BTK Disease: Impact of Lesion Type, Severity, and Location on Technique and Device Selection

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

My Toughest BTK Case of the Year

Optimal BTK POBA: Is There Science to the Art?

Clinical Trial Updates: BTK Tacks, Scaffolds, and Drugs

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

Intact Vascular Announces US Launch of the Tack Endovascular System® and First Commercial Use

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

LUTONIX BTK Trial

LUTONIX BTK: Hope for Challenging Patients at High Risk for Amputation

DCB for BTK: Clinical Challenges and Lessons Learned

A Novel Micro-stent Technology Platform for BTK Interventions (Micromedical)

Trial Strategies to Prove the Value of New BTK Devices

Maximizing Long-term Outcome: DES, DCB, and Combination Therapies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content